Publications Amylose AL et autres maladies par dépôt d'immunoglobulines monoclonales

Heavy Chain Fibrillary Glomerulonephritis: A Case Report.

Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Comprehensive molecular characterization of a heavy chain deposition disease case.

Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications.

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy.

Monoclonal gammopathy related disorders

Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study

Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study

Comparison of echocardiographic parameters in Fabry cardiomyopathy and light-chain cardiac amyloidosis

Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p

Comprehensive molecular characterization of a heavy chain deposition disease case

Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications

Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications.

Comprehensive molecular characterization of a heavy chain deposition disease case.

Intensive haemodialysis using PMMA dialyser does not increase renal response rate in multiple myeloma patients with acute kidney injury.

Animal models of monoclonal immunoglobulin-related renal diseases.

Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial. Bridoux F et al. JAMA. 2017 Dec 5.

VLITL is a major cross-β-sheet signal for fibrinogen Aα-chain frameshift variants. Garnier C et al. Blood. 2017 Dec 21.

Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial. Dimopoulos M et al. J Clin Oncol. 2018 Feb 2.

[Classification and therapeutic management of monoclonal gammopathies of renal significance]. Javaugue V et al. Rev Med Interne. 2018 Mar.

Animal models of monoclonal immunoglobulin-related renal diseases. Sirac C et al. Nat Rev Nephrol. 2018 Apr.

Eculizumab reversed severe distal ischemic syndrome and glomerulonephritis with isolated C3 deposits associated with anti-factor H autoantibodies: a case report. Deshayes S et al. Clin Rheumatol. 2018 Apr.

Intensive haemodialysis using PMMA dialyser does not increase renal response rate in multiple myeloma patients with acute kidney injury. Hudier L et al. Clin Kidney J. 2018 Apr.

Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study. Sens F et al. Am J Nephrol. 2017 Oct 10;46(5):355-363.

A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis. Sanchorawala V et al. Blood. 2017 Aug 3;130(5):597-605.

Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays. Palladini G et al. Clin Chem Lab Med. 2017 Oct 26;55(11):1734-1743.

Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of
dexamethasone in primary light-chain cardiac amyloidosis. Le Bras F et al. Eur J Cancer. 2017
May;76:183-187.

Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis. Mohty D et al. Clin Res Cardiol. 2017 May;106(5):331-340.

Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy. Chauvet S et al. Blood 2017
 
The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits. Vignon M et al. Kidney Int 2017
 
Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management. Bridoux F et al. Kidney Int. 2017
 
Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients. Vignon M et al. Leukemia. 2017